Clinical Trials
3 trialsNCT00376064 2017-03-06
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Novartis
Phase 4 Completed
NCT00976508 2013-12-13
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT00017927 2008-03-04
A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
National Institutes of Health Clinical Center (CC)
Phase 3 Completed